Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19

This case-control study examines the association between receipt of the bradykinin 2 (B2) receptor antagonist icatibant and improved oxygenation in patients with coronavirus disease 2019 (COVID-19).

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Netw Open
Main Authors: van de Veerdonk, Frank L., Kouijzer, Ilse J. E., de Nooijer, Aline H., van der Hoeven, Hans G., Maas, Coen, Netea, Mihai G., Brüggemann, Roger J. M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Research Letter
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7426743/
https://ncbi.nlm.nih.gov/pubmed/32789513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.17708
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados